Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch

NAActive, not recruitingINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

February 20, 2024

Primary Completion Date

July 1, 2024

Study Completion Date

October 1, 2024

Conditions
Cardiac ArrhythmiaDiagnostic/Monitoring Devices Related to Adverse Incidents
Interventions
DEVICE

HeartWatch

The HeartWatch is indicated for the extended diagnostic evaluation of patients with symptomatic and transient symptoms such as light-headedness, syncope, and palpitations, as well as patients at risk for arrhythmias, but without significant symptoms. It is an armband consisting of the main body of the device with an additional sensor located on the band. It is worn around the upper left arm to obtain heart electrical signals. The device is paired with the HelpWear application on a smartphone where the signals are stored and then will be uploaded to a secure network for analysis.

Trial Locations (1)

T2N 4N1

Foothills Medical Centre University of Calgary, Calgary

All Listed Sponsors
lead

HelpWear Inc.

INDUSTRY